{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:41:47Z","timestamp":1770482507217,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T00:00:00Z","timestamp":1361923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T00:00:00Z","timestamp":1361923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12672-013-0135-0","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T19:57:41Z","timestamp":1361908661000},"page":"154-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Androgen Receptor Protein Levels Are Significantly Reduced in Serous Ovarian Carcinomas Compared with Benign or Borderline Disease but Are Not altered by Cancer Stage or Metastatic Progression"],"prefix":"10.1007","volume":"4","author":[{"given":"Miriam S.","family":"Butler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Ricciardelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne D.","family":"Tilley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa E.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"issue":"1","key":"135_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<40::AID-IJC6>3.0.CO;2-E","volume":"86","author":"MH Ahonen","year":"2000","unstructured":"Ahonen MH, Zhuang YH, Aine R, Ylikomi T, Tuohimaa P (2000) Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer 86(1):40\u201346","journal-title":"Int J Cancer"},{"issue":"3","key":"135_CR2","first-page":"281","volume":"25","author":"N Auersperg","year":"1998","unstructured":"Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC (1998) The biology of ovarian cancer. Semin Oncol 25(3):281\u2013304","journal-title":"Semin Oncol"},{"issue":"2","key":"135_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0020-7292(00)00300-3","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70(2):209\u2013262","journal-title":"Int J Gynaecol Obstet"},{"issue":"20","key":"135_CR4","doi-asserted-by":"publisher","first-page":"10087","DOI":"10.1158\/0008-5472.CAN-07-1646","volume":"67","author":"G Buchanan","year":"2007","unstructured":"Buchanan G, Ricciardelli C, Harris JM, Prescott J, Zoe Chiao-Li Y, Jia L, Butler LM et al (2007) Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein {alpha}. Cancer Res 67(20):10087\u201310096","journal-title":"Cancer Res"},{"issue":"24","key":"135_CR5","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351(24):2519\u20132529","journal-title":"N Engl J Med"},{"issue":"2","key":"135_CR6","first-page":"231","volume":"17","author":"MR Cardillo","year":"1998","unstructured":"Cardillo MR, Petrangeli E, Aliotta N, Salvatori L, Ravenna L, Chang C, Castagna G (1998) Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J Exp Clin Cancer Res 17(2):231\u2013237","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"135_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10549-010-0761-y","volume":"124","author":"I Castellano","year":"2010","unstructured":"Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R, Durando A et al (2010) Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast Cancer Res Treat 124(3):607\u2013617. doi:10.1007\/s10549-010-0761-y","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"135_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0046-8177(93)90067-Q","volume":"24","author":"S Chadha","year":"1993","unstructured":"Chadha S, Rao BR, Slotman BJ, van Vroonhoven CC, van der Kwast TH (1993) An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Hum Pathol 24(1):90\u201395","journal-title":"Hum Pathol"},{"issue":"14","key":"135_CR9","first-page":"5142","volume":"9","author":"CM Cottreau","year":"2003","unstructured":"Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT (2003) Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. Clin Cancer Res 9(14):5142\u20135144","journal-title":"Clin Cancer Res"},{"issue":"4","key":"135_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000094097","volume":"62","author":"DS Dizon","year":"2006","unstructured":"Dizon DS, Tejada-Berges T, Koelliker S, Steinhoff M, Granai CO (2006) Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient. Gynecol Obstet Invest 62(4):226\u2013228","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"135_CR11","first-page":"929","volume":"60","author":"A Evangelou","year":"2000","unstructured":"Evangelou A, Jindal SK, Brown TJ, Letarte M (2000) Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Cancer Res 60(4):929\u2013935","journal-title":"Cancer Res"},{"issue":"3","key":"135_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1006\/gyno.1999.5720","volume":"76","author":"JJ Hage","year":"2000","unstructured":"Hage JJ, Dekker JJ, Karim RB, Verheijen RH, Bloemena E (2000) Ovarian cancer in female-to-male transsexuals: report of two cases. Gynecol Oncol 76(3):413\u2013415","journal-title":"Gynecol Oncol"},{"issue":"8","key":"135_CR13","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1210\/me.2012-1107","volume":"26","author":"TE Hickey","year":"2012","unstructured":"Hickey TE, Robinson JL, Carroll JS, Tilley WD (2012) Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 26(8):1252\u20131267. doi:10.1210\/me.2012-1107me.2012-1107","journal-title":"Mol Endocrinol"},{"issue":"2","key":"135_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1006\/gyno.1997.4764","volume":"66","author":"JV Ilekis","year":"1997","unstructured":"Ilekis JV, Connor JP, Prins GS, Ferrer K, Niederberger C, Scoccia B (1997) Expression of epidermal growth factor and androgen receptors in ovarian cancer. Gynecol Oncol 66(2):250\u2013254. doi:10.1006\/gyno.1997.4764","journal-title":"Gynecol Oncol"},{"issue":"3","key":"135_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/00004347-198709000-00006","volume":"6","author":"R Kuhnel","year":"1987","unstructured":"Kuhnel R, Delemarre JF, Rao BR, Stolk JG (1987) Correlation of multiple steroid receptors with histological type and grade in human ovarian cancer. Int J Gynecol Pathol 6(3):248\u2013256","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"135_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00428-009-0824-9","volume":"456","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, McConnell TG (2010) Precursors of endometrial and ovarian carcinoma. Virchows Arch 456(1):1\u201312. doi:10.1007\/s00428-009-0824-9","journal-title":"Virchows Arch"},{"issue":"7","key":"135_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman RJ, Shih Ie M (2011) Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm. Hum Pathol 42(7):918\u2013931. doi:10.1016\/j.humpath.2011.03.003","journal-title":"Hum Pathol"},{"issue":"10","key":"135_CR18","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1073\/pnas.96.10.5722","volume":"96","author":"KM Lau","year":"1999","unstructured":"Lau KM, Mok SC, Ho SM (1999) Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 96(10):5722\u20135727","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"135_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ygyno.2004.11.010","volume":"96","author":"P Lee","year":"2005","unstructured":"Lee P, Rosen DG, Zhu C, Silva EG, Liu J (2005) Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer. Gynecol Oncol 96(3):671\u2013677. doi:10.1016\/j.ygyno.2004.11.010","journal-title":"Gynecol Oncol"},{"issue":"6","key":"135_CR20","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/sj.onc.1209836","volume":"26","author":"CT Leong","year":"2007","unstructured":"Leong CT, Ong CK, Tay SK, Huynh H (2007) Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro. Oncogene 26(6):870\u2013880. doi:10.1038\/sj.onc.1209836","journal-title":"Oncogene"},{"issue":"2","key":"135_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10549-011-1715-8","volume":"130","author":"S Loibl","year":"2011","unstructured":"Loibl S, Muller BM, von Minckwitz G, Schwabe M, Roller M, Darb-Esfahani S, Ataseven B et al (2011) Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat 130(2):477\u2013487. doi:10.1007\/s10549-011-1715-8","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"135_CR22","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Sch\u00fctz G, Umesono K, Blumberg B et al (1995) The nuclear receptor superfamily: the second decade. Cell 83(6):835\u2013839","journal-title":"Cell"},{"key":"135_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1757-2215-3-14","volume":"3","author":"B Nodin","year":"2010","unstructured":"Nodin B, Zendehrokh N, Brandstedt J, Nilsson E, Manjer J, Brennan DJ, Jirstrom K (2010) Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival. J Ovarian Res 3:14. doi:10.1186\/1757-2215-3-14","journal-title":"J Ovarian Res"},{"issue":"10","key":"135_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1634\/theoncologist.2011-0164","volume":"16","author":"D Papadatos-Pastos","year":"2011","unstructured":"Papadatos-Pastos D, Dedes KJ, de Bono JS, Kaye SB (2011) Revisiting the role of antiandrogen strategies in ovarian cancer. Oncologist 16(10):1413\u20131421. doi:10.1634\/theoncologist.2011-0164theoncologist.2011-0164","journal-title":"Oncologist"},{"issue":"1","key":"135_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2004.12.037","volume":"231","author":"J Prescott","year":"2006","unstructured":"Prescott J, Coetzee GA (2006) Molecular chaperones throughout the life cycle of the androgen receptor. Cancer Lett 231(1):12\u201319","journal-title":"Cancer Lett"},{"issue":"3","key":"135_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.maturitas.2009.01.001","volume":"62","author":"C Ricciardelli","year":"2009","unstructured":"Ricciardelli C, Oehler MK (2009) Diverse molecular pathways in ovarian cancer and their clinical significance. Maturitas 62(3):270\u2013275. doi:10.1016\/j.maturitas.2009.01.001","journal-title":"Maturitas"},{"issue":"4 Pt 1","key":"135_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/0029-7844(96)00226-8","volume":"88","author":"JM Schildkraut","year":"1996","unstructured":"Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88(4 Pt 1):554\u2013559","journal-title":"Obstet Gynecol"},{"key":"135_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jcb.240590928","volume":"23","author":"RE Scully","year":"1995","unstructured":"Scully RE (1995) Pathology of ovarian cancer precursors. J Cell Biochem Suppl 23:208\u2013218","journal-title":"J Cell Biochem Suppl"},{"issue":"3","key":"135_CR29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/sj.bjc.6605153","volume":"101","author":"LA Sheach","year":"2009","unstructured":"Sheach LA, Adeney EM, Kucukmetin A, Wilkinson SJ, Fisher AD, Elattar A, Robson CN, Edmondson RJ (2009) Androgen-related expression of G-proteins in ovarian cancer. Br J Cancer 101(3):498\u2013503. doi:10.1038\/sj.bjc.6605153","journal-title":"Br J Cancer"},{"issue":"9","key":"135_CR30","first-page":"879","volume":"10","author":"EG Silva","year":"1997","unstructured":"Silva EG et al (1997) The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod Pathol 10(9):879\u2013883","journal-title":"Mod Pathol"},{"issue":"1","key":"135_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0090-8258(89)90607-0","volume":"33","author":"BJ Slotman","year":"1989","unstructured":"Slotman BJ, Kuhnel R, Rao BR, Dijkhuizen GH, de Graaff J, Stolk JG (1989) Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival. Gynecol Oncol 33(1):76\u201381. doi:0090-8258(89)90607-0","journal-title":"Gynecol Oncol"},{"issue":"15","key":"135_CR32","first-page":"4096","volume":"54","author":"WD Tilley","year":"1994","unstructured":"Tilley WD, Lim-Tio SS, Horsfall DJ, Aspinall JO, Marshall VR, Skinner JM (1994) Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res 54(15):4096\u20134102","journal-title":"Cancer Res"},{"issue":"3","key":"135_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/jcp.53.3.201","volume":"53","author":"HC van Doorn","year":"2000","unstructured":"van Doorn HC, Burger CW, van der Valk P, Bonfrer HM (2000) Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses. J Clin Pathol 53(3):201\u2013205","journal-title":"J Clin Pathol"},{"issue":"5","key":"135_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih Ie M, Kurman RJ (2009) Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 16(5):267\u2013282. doi:10.1097\/PAP.0b013e3181b4fffa00125480-200909000-00001","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"135_CR35","doi-asserted-by":"publisher","first-page":"864","DOI":"10.4161\/cbt.6.6.4093","volume":"6","author":"Y Wang","year":"2007","unstructured":"Wang Y, Yang J, Gao Y, Dong LJ, Liu S, Yao Z (2007) Reciprocal regulation of 5alpha-dihydrotestosterone, interleukin-6 and interleukin-8 during proliferation of epithelial ovarian carcinoma. Cancer Biol Ther 6(6):864\u2013871","journal-title":"Cancer Biol Ther"},{"issue":"7","key":"135_CR36","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/ijc.25494","volume":"128","author":"MP Ween","year":"2011","unstructured":"Ween MP, Lokman NA, Hoffmann P, Rodgers RJ, Ricciardelli C, Oehler MK (2011) Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int J Cancer 128(7):1570\u20131584. doi:10.1002\/ijc.25494","journal-title":"Int J Cancer"},{"issue":"6","key":"135_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0010-7824(95)00098-U","volume":"51","author":"I Wiegratz","year":"1995","unstructured":"Wiegratz I, Jung-Hoffmann C, Kuhl H (1995) Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception 51(6):341\u2013346","journal-title":"Contraception"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-013-0135-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-013-0135-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-013-0135-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-013-0135-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T16:06:31Z","timestamp":1609776391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-013-0135-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1007\/s12672-013-0135-0","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]},"assertion":[{"value":"8 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}